Long Non Coding RNA in Complications of Systemic Lupus
NCT03185767 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2017-06-14
Summary
the precise role of RNA in setting of this complication in systemic lupus erythematosus (SLE) is largely unknown
Conditions
- Complication in Systemic Lupus Erythematosus
Interventions
- OTHER
-
blood sampling
blood sampling
Sponsors & Collaborators
-
Cairo University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-06-01
- Primary Completion
- 2017-06-30
- Completion
- 2017-07-01
Countries
- Egypt
Study Locations
More Related Trials
-
Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis
NCT02756546 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)
NCT05394922 ·Status: RECRUITING
-
Clinical and Diagnostic Value of Ribosomal p2 Autoantibodies in Systemic Lupus Erythematosus
NCT05179018 ·Status: UNKNOWN
-
Urinary Congophilia As an Indicator of Activity of Lupus Nephritis
NCT06654024 ·Status: NOT_YET_RECRUITING
-
Gynecological Symptoms and Health-related Quality of Life in Egyptian Women With SLE
NCT05230316 ·Status: UNKNOWN
-
Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization
NCT03142412 ·Status: UNKNOWN
-
O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus
NCT04440566 ·Status: COMPLETED ·Phase: NA
-
Autoimmunity in Sisters of Lupus Patients
NCT01076101 ·Status: COMPLETED
-
Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus
NCT05057481 ·Status: UNKNOWN ·Phase: PHASE3
-
SSerum/Urinary Monocyte Chemoattractant Protein-1 Level as a Marker for Lupus Nephritis
NCT03164720 ·Status: UNKNOWN
-
Anti-nucleosome B Lymphocytes in Lupus
NCT01889654 ·Status: TERMINATED
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Anti-ficolin-3 Antibodies in Lupus Nephritis
NCT03842787 ·Status: COMPLETED
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Serologically Active, Clinically Stable Systemic Lupus Erythematosus
NCT00000421 ·Status: COMPLETED ·Phase: PHASE2
-
Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus
NCT02456168 ·Status: COMPLETED
-
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
NCT01470183 ·Status: COMPLETED
-
Photoprovocation Testing in Subjects With Cutaneous Lupus
NCT01516788 ·Status: COMPLETED ·Phase: NA
-
AntiDFS70 Lupus Nephritis
NCT06119763 ·Status: RECRUITING
-
Dynamic Imaging of Variation in Lupus Nephritis
NCT03180021 ·Status: COMPLETED
-
NCF Gene & TNFSF4 in SLE Patients
NCT05314881 ·Status: UNKNOWN ·Phase: NA
-
Renal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity
NCT06757725 ·Status: COMPLETED ·Phase: NA
-
Ferroptosis Role in the Pathophysiology of Systemic Lupus Erythematosus
NCT07260942 ·Status: RECRUITING ·Phase: NA
-
Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients
NCT06631404 ·Status: RECRUITING
-
Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus
NCT05443516 ·Status: RECRUITING